(Q40160845)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28643544%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

title

Varicella-zoster meningovasculitis in a multiple sclerosis patient treated with natalizumab (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28643544%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28643544%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Manuel Requena

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28643544%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Jordi Rio

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28643544%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Mar Tintoré

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28643544%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Xavier Montalban

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28643544%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

author name string

Patricia Mulero

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28643544%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Cristina Auger

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28643544%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Laura Parolin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28643544%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Alex Rovira

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28643544%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

publication date

23 June 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28643544%20AND%20SRC:MED&resulttype=core&format=json

Multiple Sclerosis Journal

23 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28643544%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28643544%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28643544%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

page(s)

358-360

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28643544%20AND%20SRC:MED&resulttype=core&format=json

Central nervous system herpes simplex and varicella zoster virus infections in natalizumab-treated patients

23 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458517711569

Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458517711569

Varicella-zoster virus acute myelitis in a patient with MS treated with natalizumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458517711569

Three cases of herpes zoster radiculitis in MS patients treated with natalizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458517711569

Varicella zoster-associated retinal and central nervous system vasculitis in a patient with multiple sclerosis treated with natalizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458517711569

Varicella-zoster virus infections in patients treated with fingolimod: risk assessment and consensus recommendations for management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458517711569

Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458517711569

Significant clinical worsening after natalizumab withdrawal: Predictive factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458517711569

21 January 2018

Identifiers

DOI

10.1177/1352458517711569

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28643544%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

1 reference